Chapter 17 — Breathing And Exchange Of Gases

Fig 1 — Educational Diagram: Introduction and Need for Respiration

What is respiration? Respiration is a biochemical process by which organisms obtain energy from organic molecules (mainly glucose) by controlled oxidation. The energy released is stored in the form of ATP and used for cellular activities. Note: breathing (ventilation) is a physical process that brings in O2 and removes CO2; respiration is the cellular process that harvests energy.

Levels of respiration

• External/Organismic (breathing): Exchange of gases between the environment and body (lungs/gills).
• Internal/Tissue: Exchange of gases between blood and body tissues.
• Cellular/Physiological: Oxidation of food molecules to produce ATP (glycolysis, Krebs cycle, electron transport chain).

Why is respiration needed?

• ATP production: ATP powers metabolic processes — muscle contraction, active transport, biosynthesis, nerve impulse transmission and cell division.
• Maintenance of internal order: Energy is required to maintain concentration gradients, cell structure and homeostasis.
• Reduction–oxidation balance: Respiration provides a controlled way to remove electrons from food and transfer them to an electron acceptor (usually O2).
• Removal of waste: CO2 produced needs to be eliminated; continuous gas exchange prevents accumulation of toxic products.

Aerobic vs anaerobic respiration

• Aerobic: Uses O2 as final electron acceptor; yields large amount of ATP (theoretical max ≈ 38 ATP per glucose). Occurs in mitochondria (Krebs cycle + oxidative phosphorylation).
• Anaerobic (fermentation): Occurs without O2; yields small ATP (2 ATP/glucose). Produces end products such as lactic acid (animals) or ethanol + CO2 (yeast).

Role of gas exchange in respiration

• O2 must continuously diffuse into the respiratory surface and be transported to cells; CO2 produced must diffuse out. Diffusion follows partial pressure gradients (from high to low PO2 and PCO2).
• Effective respiration requires a large, moist respiratory surface and mechanisms (breathing, circulatory transport) to maintain gradients.

Summary: Respiration is essential because it converts chemical energy in food into usable ATP and keeps cellular processes running. Breathing and gas exchange supply O2 and remove CO2 so cellular respiration can proceed efficiently.

Fig 2 — Educational Diagram: Respiratory Organs in Different Organisms

Overview: Different organisms use a variety of respiratory organs adapted to their size, habitat and metabolic needs. All effective respiratory systems share the same basic requirements: a large surface area, a thin moist respiratory surface, a mechanism to maintain a partial pressure (concentration) gradient for gases, and (in many animals) a transport system (blood) to carry gases.

Unicellular and very small multicellular organisms

• Mode: Simple diffusion across the cell membrane or entire body surface.
• Examples: Amoeba, Paramecium, many planktonic protists, and some flatworms (e.g., planaria).
• Features: Very high surface area to volume (SA:V) ratio and very short diffusion distances.

Poriferans and Cnidarians

• Mode: Gas exchange across thin body walls; water currents (sponges) or direct diffusion (hydra).
• Adaptation: Body design maximizes contact with water.

Earthworms and some amphibians (cutaneous respiration)

• Mode: Gas exchange through moist skin.
• Features: Highly vascularized skin, mucus to keep surface moist; limited to habitats that keep the skin wet.

Crustaceans and some molluscs (gills)

• Mode: External or internal gills bathed in water; gas exchange across thin lamellae.
• Features: Large surface area formed by filaments/lamellae; some use ventilatory movements or appendage motion to move water.

Fishes (gills with counter-current exchange)

• Structure: Gill arches → gill filaments → secondary lamellae (thin sheets of capillaries).
• Mechanism: Water flows over lamellae in one direction while blood flows in the opposite direction (counter-current), maintaining a diffusion gradient along the entire lamella and maximizing O2 uptake.

Insects (tracheal system)

• Structure: Open spiracles → branching tracheae → finest tracheoles that reach cells.
• Mechanism: Air is delivered directly to tissues; diffusion is sufficient over short distances; ventilation (abdominal pumping) can augment flow in active insects.
• Limitations: Direct oxygen delivery removes need for respiratory pigments, but places an upper limit on body size because diffusion is distance-limited.

Amphibians (lungs + skin), Reptiles (lungs), Mammals (lungs with alveoli)

• Amphibians: Use buccal pumping to ventilate simple sac-like lungs and also rely on skin for gas exchange.
• Reptiles: More developed lungs with larger internal surface area; usually use rib movements to ventilate.
• Mammals: Highly branched bronchial tree ending in alveoli. Alveoli provide a very large surface area and extremely thin respiratory membrane for efficient diffusion; ventilation by diaphragm and intercostal muscles.

Birds (lungs + air sacs; unidirectional flow)

• Structure: Small rigid lungs plus multiple air sacs. Air flows in a largely unidirectional path through parabronchi and air capillaries.
• Advantage: Continuous flow of fresh air through gas-exchange regions during both inhalation and exhalation, very efficient O2 extraction (important for high metabolic rates and flight).

General adaptations common to efficient respiratory organs

• Large total surface area (folding, branching, lamellae, alveoli).
• Thin respiratory membranes to minimize diffusion distance.
• Moist surfaces to dissolve gases (except tracheal air in insects where terminal tracheoles remain moist).
• Constant maintenance of a concentration gradient by ventilation (moving external medium) and perfusion (blood flow).

Key physiological principles: Diffusion of gases follows partial pressure differences. Respiratory efficiency depends on surface area, diffusion distance, solubility of gases, and the gradient in partial pressures. Circulatory adaptations (e.g., hemoglobin binding O2) and ventilatory mechanisms (diaphragm, buccal pumping, opercular movements, abdominal pumping) maintain gradients.

Fig 3 — Educational Diagram: Human Respiratory System — External Structure and Organs

Overview
The human respiratory system provides a surface for gas exchange (O2 in, CO2 out) and a conducting pathway to bring air to and from the lungs. It is anatomically divided into the upper respiratory tract (external nose, nasal cavity, pharynx, and associated structures) and the lower respiratory tract (larynx, trachea, bronchi, bronchioles and alveoli within the lungs). Respiratory muscles (diaphragm and intercostals) create pressure changes that ventilate the lungs.

External nose and nasal cavity
The external nose is supported by bone (nasal bones) and cartilage and opens via two nostrils (nares). Air enters the nasal vestibule (lined with skin and coarse hairs) which traps large particles. The nasal cavity extends posteriorly and is divided by the nasal septum (cartilage anteriorly, bone posteriorly). The lateral walls have three nasal conchae (turbinates) that increase surface area and create turbulent airflow.

• Functions: warm, humidify and filter inspired air; olfaction (upper part of nasal cavity with olfactory epithelium); resonance for voice.
• Adaptations: pseudostratified ciliated columnar epithelium with goblet cells (mucus) and cilia that form the mucociliary escalator to trap and move particles toward the pharynx.

Pharynx (throat)
A fibromuscular tube shared by respiratory and digestive systems. It has three regions: nasopharynx (behind nasal cavity; air only), oropharynx (behind oral cavity; air and food), and laryngopharynx (connects to larynx and esophagus). The pharynx conducts air to the larynx and participates in swallowing and immunological defence (tonsils).

Larynx (voice box)
Cartilaginous structure that connects pharynx to trachea. Key cartilages include the thyroid (Adam's apple), cricoid, and epiglottis. The epiglottis covers the glottis during swallowing to prevent aspiration. Vocal cords (folds) in the larynx produce sound when air passes through.

Trachea and bronchi
The trachea is a flexible tube supported by C-shaped hyaline cartilage rings that keep the airway open and allow flexibility. It bifurcates at the sternal angle into right and left primary bronchi. Bronchi branch repeatedly (secondary, tertiary) into smaller bronchi and bronchioles—forming the bronchial tree. Cartilage becomes sparse and smooth muscle increases in smaller airways, allowing regulation of airway diameter.

Bronchioles and alveoli
Terminal bronchioles lead to respiratory bronchioles and alveolar ducts which end in alveolar sacs composed of many alveoli. Alveoli are the primary sites of gas exchange. They are thin-walled (type I pneumocytes), lined by type II pneumocytes that secrete surfactant (which lowers surface tension and prevents collapse), and richly supplied with capillaries. The alveolar–capillary membrane is extremely thin to allow rapid diffusion of gases.

Lungs and pleura
The paired lungs occupy the thoracic cavity. The right lung has three lobes (superior, middle, inferior), the left has two lobes (superior, inferior) and a cardiac notch to accommodate the heart. Each lung is covered by a serous membrane called pleura—visceral pleura adheres to lung surface; parietal pleura lines the thoracic wall. The pleural cavity between them contains a small amount of fluid to reduce friction and maintain negative pressure.

Respiratory muscles
Diaphragm (dome-shaped skeletal muscle) forms the floor of the thoracic cavity and is the primary muscle of inspiration. External intercostals assist inspiration by raising ribs; internal intercostals and abdominal muscles assist forced expiration. Contraction increases thoracic volume, lowering intrapulmonary pressure and drawing air in; relaxation raises pressure and expels air.

Important functional features & clinical notes

• Mucociliary escalator: mucus from goblet cells traps particles; cilia move mucus upward to be swallowed—key defense against infection.
• Surfactant deficiency (premature infants) causes increased surface tension and respiratory distress.
• Smoking damages cilia, increases mucus, and causes chronic bronchitis / emphysema.
• Obstruction or inflammation in any conducting region (e.g., deviated septum, sinusitis, asthma) affects ventilation and gas exchange.

Pathway of an inspired air molecule
Nostrils → nasal vestibule → nasal cavity (conchae) → nasopharynx → oropharynx → laryngopharynx → larynx → trachea → primary bronchus → secondary/tertiary bronchi → bronchiole → alveolar duct → alveolus.

Fig 4 — Educational Diagram: Histology of Respiratory Tract

Overview
The respiratory tract is lined by different epithelia and supporting tissues specialized for air conduction, cleaning, warming/humidifying inspired air and for efficient gas exchange in the alveoli. Histological structure changes progressively from the nasal cavity down to the alveoli to match function.

Major regions and their histology

• Nasal cavity: Lined mainly by pseudostratified ciliated columnar epithelium (respiratory epithelium) with numerous goblet cells. Lamina propria contains rich vascular network (warms air) and seromucous glands (humidify). Olfactory area has olfactory epithelium with bipolar neurons.
• Pharynx: Nasopharynx: respiratory epithelium. Oropharynx and laryngopharynx are lined by non-keratinized stratified squamous epithelium to resist abrasion from swallowed food.
• Larynx: Mixed epithelium: stratified squamous over vocal cords, respiratory epithelium elsewhere. Lamina propria has elastic tissue; cartilages (mainly hyaline and elastic) provide support.
• Trachea: Mucosa—respiratory epithelium (pseudostratified ciliated columnar with goblet cells); lamina propria with seromucous glands; submucosa with more glands. Cartilage—C-shaped hyaline cartilage rings open posteriorly; trachealis (smooth) muscle bridges the open ends. Function: conduction + mucociliary clearance.
• Bronchi: Similar to trachea histology but with smaller diameter: respiratory epithelium (still pseudostratified), goblet cells, seromucous glands, and cartilage in irregular plates rather than rings. As bronchi branch, epithelium becomes lower and cartilage decreases.
• Bronchioles: Smaller airways (<1 mm) with no cartilage and fewer glands. Epithelium transitions from ciliated columnar to ciliated cuboidal. Goblet cells become sparse; club (Clara) cells appear in terminal bronchioles—nonciliated, dome-shaped cells that secrete surfactant-like substances, detoxify inhaled toxins and act as progenitor cells.
• Respiratory bronchioles & alveolar ducts: Sites where simple squamous alveoli begin to appear in walls; these structures allow some gas exchange.
• Alveoli (gas-exchange units):
  • Alveolar lining cells: Type I pneumocytes—extremely thin squamous cells covering ~95% of alveolar surface and forming the major part of the blood–air barrier.
  • Type II pneumocytes (septal cells): cuboidal cells that secrete pulmonary surfactant (reduce surface tension), act as progenitor cells for type I cells.
  • Alveolar macrophages (dust cells): remove inhaled particles and pathogens.
  • Interalveolar septum: contains capillaries, elastic and reticular fibers, and connective tissue. Pores of Kohn interconnect neighbouring alveoli.

Blood–air (respiratory) membrane
Very thin barrier for rapid diffusion composed of: alveolar epithelial cell (type I), fused basement membrane(s) of epithelium and capillary endothelium, and capillary endothelial cell. Typical total thickness ~0.2–0.6 μm (commonly cited ~0.5 μm) enabling efficient gas exchange.

Functional specializations

• Mucociliary escalator: Coordinated beating of cilia of pseudostratified epithelium moves mucus (produced by goblet cells and submucosal glands) upward to clear debris and pathogens.
• Surfactant: Secreted by type II pneumocytes; lowers surface tension to prevent alveolar collapse and reduces work of breathing.
• Elastic fibers and smooth muscle: Provide recoil for expiration and regulate airway diameter (bronchoconstriction/dilation).

Clinical correlations (brief)

• Smoking damages cilia and increases goblet cells → impaired mucociliary clearance → chronic bronchitis.
• Asthma: hyperreactive smooth muscle in bronchioles leading to narrowing and mucus plugging.
• Emphysema: destruction of alveolar walls (loss of surface area and elastic recoil) → impaired gas exchange.
• Neonatal respiratory distress syndrome: surfactant deficiency in premature infants, alveolar collapse.

Key numbers: ~300 million alveoli in adult lung; total alveolar surface area ≈ 50–100 m² (commonly cited ≈70 m²). Blood–air barrier thickness ≈ 0.2–0.6 μm.

Fig 5 — Educational Diagram: Mechanism of Breathing (Pulmonary Ventilation)

Overview: Pulmonary ventilation (breathing) is the physical movement of air into and out of the lungs. It depends on changes in thoracic volume produced by respiratory muscles that alter intrapulmonary pressure relative to atmospheric pressure, causing airflow.

Basic physics: Air moves from high to low pressure. For the lung system, Boyle's law applies: at a constant temperature, P × V = constant. If thoracic (and thus lung) volume increases, intrapulmonary pressure falls below atmospheric and air flows in (inspiration). If lung volume decreases, intrapulmonary pressure rises above atmospheric and air flows out (expiration).

Primary muscles and movements:

• Diaphragm: contraction flattens the dome, increasing vertical thoracic volume (major muscle of quiet inspiration).
• External intercostal muscles: lift ribs up and out, increasing anteroposterior and lateral thoracic dimensions.
• Expiration at rest: mostly passive — elastic recoil of lungs and chest wall returns volume to resting level.
• Forced expiration: internal intercostals and abdominal muscles contract to actively decrease thoracic volume.

Pressures and pleura: The lungs are apposed to the thoracic wall by the pleural sacs with a small fluid-filled intrapleural space. Intrapleural pressure is normally negative (subatmospheric) which keeps lungs expanded. Important pressure relationships:

• Atmospheric pressure (Patm) ≈ 760 mmHg.
• Intrapulmonary (alveolar) pressure (Palv): fluctuates by a few cm H2O during quiet breathing (≈ -1 cm H2O during inspiration, +1 cm H2O during expiration).
• Intrapleural pressure (Pip): negative at rest (≈ -5 cm H2O) and becomes slightly more negative during inspiration.
• Transpulmonary pressure = Palv - Pip; this pressure keeps alveoli open (positive value).

Surface tension & surfactant: Alveolar walls have a thin fluid film producing surface tension that tends to collapse alveoli. Pulmonary surfactant (produced by type II pneumocytes) lowers surface tension, stabilizes alveoli of different sizes, reduces the work of breathing and prevents alveolar collapse (atelectasis). Laplace's relation for a sphere (useful conceptually): P = 2T / r (pressure to keep an alveolus open is proportional to surface tension T and inversely proportional to radius r).

Volumes & capacities (typical adult values):

• Tidal volume (TV) ≈ 500 mL
• Inspiratory reserve volume (IRV) ≈ 3000 mL
• Expiratory reserve volume (ERV) ≈ 1100 mL
• Residual volume (RV) ≈ 1200 mL
• Vital capacity (VC) = TV + IRV + ERV ≈ 4600 mL
• Total lung capacity (TLC) = VC + RV ≈ 5800 mL

Ventilation rates: Minute ventilation (total air moved per minute) = TV × respiratory rate (e.g., 0.5 L × 12/min = 6 L/min). Alveolar ventilation corrects for dead space: Alveolar ventilation = (TV − dead space) × respiratory rate. Anatomical dead space ≈ 150 mL in adults, so alveolar ventilation ≈ (500 − 150) × 12 ≈ 4.2 L/min at rest.

Control and adjustments: During exercise, respiratory rate and tidal volume increase; deeper inspiration increases negative intrapleural pressure and thoracic expansion, increasing minute and alveolar ventilation. Mechanoreceptors, chemoreceptors (CO2, H+), and higher brain centers modulate breathing patterns.

Summary sequence of one quiet breath:

1. Diaphragm and external intercostals contract → thoracic volume increases.
2. Intrapleural pressure becomes more negative → transpulmonary pressure increases → lungs expand.
3. Alveolar pressure falls below atmospheric → air flows into lungs until Palv = Patm.
4. Muscles relax → elastic recoil reduces lung volume → Palv rises above Patm → air flows out passively until Palv = Patm.

Fig 6 — Educational Diagram: Surface Tension and Surfactant

Surface tension (γ) is the property of a liquid surface that makes it behave like a stretched elastic membrane. It arises from cohesive forces between liquid molecules and can be expressed as force per unit length (N·m⁻¹) or energy per unit area (J·m⁻²).

Why surface tension matters in the lungs
Alveoli — the tiny air sacs where gas exchange occurs — are lined by a thin film of water. Water’s surface tension tends to minimize surface area and therefore tends to collapse small air-filled spheres. If nothing opposed this, alveoli would be difficult to inflate and small alveoli would collapse into larger ones.

Laplace’s principle for alveoli
For a spherical alveolus, the pressure (ΔP) needed to keep it open against surface tension is given by Laplace’s law: ΔP = 2γ / r, where γ is surface tension and r is the alveolar radius. Thus, for a given γ, smaller alveoli (smaller r) require higher inflation pressure and are prone to collapse.

Surfactant — the lung’s natural detergent
Pulmonary surfactant is a complex mixture primarily of phospholipids (mainly dipalmitoyl phosphatidylcholine, DPPC) and specific proteins, produced and secreted by type II pneumocytes (septal cells) in the alveolar epithelium. Its main functions:

• Reduce surface tension at the air–water interface of alveoli (lower γ), making alveoli easier to inflate (increases lung compliance).
• Stabilize alveoli of different sizes: surfactant lowers surface tension more effectively as the alveolus becomes smaller (so γ decreases when r decreases), preventing collapse (atelectasis) and avoiding unequal emptying.
• Reduce the work of breathing and help keep alveoli dry by reducing capillary transudation.

Mechanism
Surfactant molecules orient at the air–liquid interface with hydrophobic tails toward air and hydrophilic heads in water, disrupting cohesive water forces and lowering surface tension. Because surfactant molecules are more concentrated when the alveolar surface area decreases (compression during exhalation), surface tension falls as radius decreases — this is key to stabilizing small alveoli.

Clinical significance

• Neonatal (Infant) Respiratory Distress Syndrome (IRDS): preterm infants often lack sufficient surfactant — their alveoli collapse, causing severe respiratory distress. Treatment: exogenous surfactant and respiratory support (CPAP, ventilation).
• Acute Respiratory Distress Syndrome (ARDS) and other lung injuries: surfactant dysfunction contributes to poor gas exchange and atelectasis.
• Surfactant increases lung compliance and reduces the energy needed for breathing; deficiency increases work of breathing.

Summary points

• Surface tension tends to collapse alveoli; surfactant reduces that tension.
• Type II pneumocytes synthesize and secrete surfactant and can proliferate to replace damaged type I cells.
• Laplace’s law (ΔP = 2γ / r) explains why surfactant is critical for stability of small alveoli.

Fig 7 — Educational Diagram: Lung Volumes and Capacities

Overview: Lung volumes are the individual components of air in the respiratory system at different phases of the breathing cycle. Lung capacities are combinations of two or more volumes that represent useful functional measures. Volumes and capacities are measured in millilitres (mL) or litres (L) and are important for assessing respiratory health.

Primary lung volumes:

• Tidal Volume (TV): Air inspired or expired in a normal quiet breath (~500 mL in an average adult).
• Inspiratory Reserve Volume (IRV): Extra air that can be inspired forcibly after a normal inspiration (~3000 mL).
• Expiratory Reserve Volume (ERV): Extra air that can be forcibly expired after a normal expiration (~1,100 mL).
• Residual Volume (RV): Air remaining in lungs after maximal forced expiration (~1,200 mL). RV prevents alveolar collapse and cannot be expelled.

Important lung capacities (each is a sum of volumes):

• Inspiratory Capacity (IC) = TV + IRV (~3,500 mL). Maximum air that can be inspired after a normal expiration.
• Functional Residual Capacity (FRC) = ERV + RV (~2,300 mL). Air left in lungs after normal expiration; equilibrium point of respiratory system.
• Vital Capacity (VC) = TV + IRV + ERV (~4,600 mL). Maximum air that can be expelled after a maximal inspiration; an important clinical measure of lung function.
• Total Lung Capacity (TLC) = VC + RV (~5,800 mL). Total volume lung can hold.

Measurement notes: A spirometer measures TV, IRV, ERV and VC but cannot directly measure RV because RV remains in lungs after maximal expiration. RV and capacities that include RV (FRC, TLC) are measured by gas-dilution techniques (helium dilution), nitrogen washout or body plethysmography.

Physiological and clinical significance:

• RV keeps alveoli open and maintains continuous gas exchange between breaths.
• VC is reduced in restrictive lung diseases (pulmonary fibrosis) reflecting decreased lung compliance.
• RV and TLC may increase in obstructive diseases (emphysema) because air trapping increases RV; flow rates fall even if TLC is relatively preserved.
• Values depend on age, sex, height, posture, physical fitness and altitude.

Static vs dynamic: Volumes and capacities are static measurements. Dynamic tests (e.g., forced expiratory volume in 1 second, FEV1) assess airflow and help differentiate obstructive vs restrictive patterns.

Practical tip for students: Memorize the four primary volumes, the four capacities (with formulas), and typical adult values. Understand which are measurable by spirometry and how diseases change these numbers.

Fig 8 — Educational Diagram: Measurement of Respiration (Spirometry)

What is spirometry?
Spirometry is the measurement of air volumes and air flow during breathing using a device called a spirometer. It is used to quantify pulmonary ventilation, evaluate lung function and diagnose respiratory disorders.

Basic principle and equipment

• Spirometer: a device that records volume of air inspired and expired and/or flow rate. Traditional wet spirometers use a floating bell in water that moves as the subject breathes; modern spirometers are electronic (pneumotachographs, turbine or ultrasonic flow sensors).
• Mouthpiece, nose clip and recording system: a disposable mouthpiece and nose clip are used. The displacement (mechanical) or flow signal (electronic) is converted to an electrical signal and recorded as a spirogram (volume or flow vs time).

Procedure (typical tests)

1. Patient is seated, nose clipped, breathes through mouthpiece.
2. Record quiet breathing (to see tidal volume).
3. For lung volumes/capacities: ask for maximal inspiration followed by maximal expiration (to measure Vital Capacity or Forced Vital Capacity).
4. Forced expiratory maneuvers are used to obtain FEV1 (volume exhaled in 1 second) and FVC (forced vital capacity).

Volumes and capacities measured/derived

• Tidal Volume (TV): air inhaled/exhaled in normal quiet breath (~500 mL in adult).
• Inspiratory Reserve Volume (IRV): extra air that can be inspired after normal inspiration.
• Expiratory Reserve Volume (ERV): extra air that can be expired after normal expiration.
• Residual Volume (RV): air remaining in lungs after maximal expiration — NOT measured by simple spirometer.
• Vital Capacity (VC): TV + IRV + ERV — volume of air that can be expelled after a maximal inhalation. (Measured as FVC if forced.)
• Total Lung Capacity (TLC): VC + RV — total volume lungs can hold (RV must be obtained by other techniques).

Key spirometric indices for clinical evaluation

• FVC: Forced Vital Capacity — total volume exhaled forcefully after maximal inspiration.
• FEV1: Forced Expired Volume in first second.
• FEV1/FVC ratio (%): proportion of FVC exhaled in first second — important for distinguishing obstructive vs restrictive disease (normal ≈ >70–80% depending on age).

Interpretation (simple rules)

• Obstructive pattern (e.g., asthma, COPD): FEV1 reduced much more than FVC → low FEV1/FVC ratio. Flow-volume loop shows scooped-out expiratory limb.
• Restrictive pattern (e.g., pulmonary fibrosis): both FEV1 and FVC reduced proportionally → normal or high FEV1/FVC ratio; volumes (TLC, VC) reduced.

Limitations and precautions

• Spirometry is effort-dependent — results require proper patient cooperation and calibration of equipment.
• Residual volume and functional residual capacity cannot be measured by simple spirometers and need body plethysmography or gas dilution methods.
• Results must be corrected/expressed for age, sex, height and ethnicity; readings are usually given as percent of predicted normal.

Clinical and practical uses
Diagnosis and monitoring of asthma and COPD, preoperative pulmonary assessment, occupational health screening, sports fitness testing, tracking response to bronchodilators.

Note for Class 11 learners: understand the definitions of the basic volumes and capacities, how a spirometer records a spirogram, the meaning of FEV1 and FVC, and how these help distinguish obstructive vs restrictive respiratory disorders.

Fig 9 — Educational Diagram: Exchange of Gases at the Respiratory Surface

Overview
Exchange of gases at the respiratory surface is the passive movement of oxygen (O2) and carbon dioxide (CO2) across a thin, moist membrane between the external medium (air or water) and the blood or body fluids. It occurs by diffusion down partial pressure gradients and is optimized by structural and physiological adaptations.

Key steps

• Diffusion at the respiratory surface: O2 diffuses from the air/water (higher pO2) into blood (lower pO2); CO2 diffuses from blood (higher pCO2) to air/water (lower pCO2).
• Transport in blood: O2 is mostly transported bound to haemoglobin (Hb) in red blood cells; a small portion is dissolved in plasma. CO2 is transported dissolved, as carbamino compounds on Hb, and mainly as bicarbonate (HCO3−) after conversion by carbonic anhydrase.
• Release at tissues: O2 is released from Hb where tissue pO2 is low; CO2 produced by cells diffuses into blood and is carried back to the respiratory surface.

Physical principles

• Diffusion driven by partial pressures: Gas movement depends on partial pressure differences (not concentration per se). Typical values in humans: alveolar pO2 ≈ 100 mmHg, arterial pO2 ≈ 95–100 mmHg, mixed venous pO2 ≈ 40 mmHg; alveolar/arterial pCO2 ≈ 40 mmHg, venous pCO2 ≈ 45 mmHg.
• Fick's law: Rate of diffusion ∝ (surface area × diffusion coefficient × partial pressure difference) / membrane thickness. Thus large area, thin membrane and large p gradient maximize exchange.
• Henry's law: Amount of gas dissolved in a liquid is proportional to its partial pressure above the liquid (important for O2 and CO2 solubility differences).

Adaptations of respiratory surfaces

• Large surface area (alveoli in mammals, lamellae in fish gills, thin body wall in earthworms).
• Very thin barrier (single or few cell layers) and moist surface for gas dissolution.
• Rich blood supply to maintain steep partial pressure gradients.
• Special mechanisms: countercurrent flow in fish gills (maximizes O2 extraction), ventilatory movements in air-breathing animals, tracheal tubes in insects deliver air directly to tissues.

Physiological details (mammals)

• At alveoli: O2 diffuses across alveolar epithelium → interstitium → capillary endothelium → plasma → RBC and binds to Hb to form oxyhaemoglobin.
• CO2 generated by tissues diffuses into blood; in RBCs it is converted to HCO3− by carbonic anhydrase. HCO3− is exchanged for Cl− (chloride shift) to maintain charge balance. At lungs the process reverses and CO2 diffuses into alveoli to be expired.
• Oxyhaemoglobin dissociation curve (sigmoidal) shows cooperative O2 binding. Factors shifting the curve right (reduced affinity) include increased temperature, increased pCO2, decreased pH (Bohr effect), and increased 2,3‑BPG; these facilitate O2 unloading at tissues.

Clinical and ecological notes
Diseases that thicken the respiratory membrane (pulmonary fibrosis) or reduce surface area (emphysema) decrease diffusion and impair gas exchange. At high altitude lower atmospheric pO2 reduces alveolar pO2 and O2 delivery; acclimatisation involves increased ventilation, increased 2,3‑BPG, and erythropoiesis.

Fig 10 — Educational Diagram: Partial Pressure and Dalton's Law

Partial pressure (P) of a gas is the pressure that gas would exert if it alone occupied the volume. In a gas mixture (like air), each gas contributes to the total pressure in proportion to its concentration (mole fraction).

Dalton's law of partial pressures: In a mixture of non-reacting gases, the total pressure (P_total) is the sum of the partial pressures of each component gas: P_total = ΣP_i. Each partial pressure P_i = X_i × P_total, where X_i is the mole fraction of the ith gas.

Why this matters in biology (breathing & gas exchange):

• Diffusion of O2 and CO2 across respiratory surfaces (alveolar-capillary membrane) is driven by differences in their partial pressures (ΔPO2, ΔPCO2), not by differences in concentrations alone.
• Oxygen moves from regions of higher PO2 to lower PO2 (e.g., alveolar air → blood); carbon dioxide moves from higher PCO2 (blood) → lower PCO2 (alveolar air).
• Changes in atmospheric pressure (altitude, hyperbaric conditions), inspired oxygen fraction (FiO2), or water vapor in the airways alter gas partial pressures and so affect gas exchange.

Typical partial pressure values (mmHg) and a worked example:

• Atmospheric pressure at sea level ≈ 760 mmHg. Dry air composition: O2 ≈ 21% → PO2 ≈ 0.21 × 760 ≈ 160 mmHg.
• Inspired air is humidified in the airway. Water vapour pressure at body temperature (37°C) ≈ 47 mmHg, so the inspired O2 pressure (PIO2) = (Patm - PH2O) × FiO2 = (760 - 47) × 0.21 ≈ 149 mmHg.
• Alveolar PO2 (PAO2) is lower (~100 mmHg) because O2 is being absorbed and CO2 is added. Alveolar PCO2 ≈ 40 mmHg. Arterial PaO2 ≈ 95 mmHg, venous PvO2 ≈ 40 mmHg; arterial PaCO2 ≈ 40 mmHg, venous PvCO2 ≈ 45 mmHg.
• Example using the alveolar gas equation: PAO2 = PIO2 - (PaCO2 / R). With PIO2 ≈ 149 mmHg, PaCO2 = 40 mmHg, respiratory exchange ratio R ≈ 0.8: PAO2 ≈ 149 - (40 / 0.8) = 149 - 50 = 99 mmHg (≈100 mmHg).

Key physiological consequences:

• At high altitude total atmospheric pressure falls → partial pressures of O2 fall → reduced PAO2 and arterial oxygenation (hypoxia).
• Breathing 100% O2 raises FiO2 and thus PO2, increasing oxygen loading (used in medical oxygen therapy and hyperbaric treatment).
• In scuba diving, increased ambient pressure raises partial pressures of inert gases (e.g., N2), which can cause toxicity (decompression sickness) on rapid ascent.

Related laws and limits: Henry's law (important for dissolved gases): the amount of gas dissolved in a liquid is proportional to its partial pressure above the liquid (C = α × P, where α is the solubility coefficient). Fick's law of diffusion describes flux across a membrane proportional to the partial pressure difference and membrane properties.

Fig 11 — Educational Diagram: Transport of Oxygen in Blood

Overview
Oxygen (O2) is carried from lungs to tissues in two forms: dissolved in plasma and chemically bound to haemoglobin (Hb) in red blood cells. Transport depends on partial pressure of oxygen (PO2), haemoglobin concentration and affinity, and factors that alter Hb–O2 binding.

Forms of O2 transport

• Dissolved O2: A small fraction dissolved directly in plasma (~0.003 mL O2 per 100 mL blood per mmHg PO2). Though small (~2–3% of total O2), it determines PO2 and thus diffusion gradients.
• Bound to haemoglobin (oxyhaemoglobin): Most O2 (~97–98%) is reversibly bound to Hb in RBCs. Each Hb molecule (4 heme groups) can bind up to 4 O2 molecules.

Basic reaction
Hb + O2 ⇌ HbO2 (reversible). Cooperative binding: binding of one O2 increases affinity for the next, producing a sigmoidal dissociation curve.

Oxyhaemoglobin dissociation curve
The curve plots PO2 (x-axis, mmHg) vs % saturation of Hb (y-axis). Key points: at arterial PO2 ≈ 100 mmHg, SaO2 ≈ 95–100%; at venous PO2 ≈ 40 mmHg, SvO2 ≈ 70–75% (typical). The steep portion (20–60 mmHg) allows large changes in O2 unloading with small PO2 changes.

Factors affecting Hb–O2 affinity (curve shifts)

• Right shift (↓ affinity, easier unloading): ↑ temperature, ↑ PCO2, ↓ pH (Bohr effect), ↑ 2,3-BPG, chronic hypoxia/exercise. Right shift increases O2 release to tissues.
• Left shift (↑ affinity, harder unloading): ↓ temperature, ↓ PCO2, ↑ pH, ↓ 2,3-BPG, fetal haemoglobin (HbF).
• Bohr effect: CO2 and H+ bind Hb changing its conformation and lowering O2 affinity, promoting O2 release in active tissues.

Physiological significance

• Lungs: high alveolar PO2 → loading of O2 onto Hb.
• Tissues: lower PO2 and higher PCO2, H+, temperature → unloading of O2.
• Myoglobin in muscle: high O2 affinity (hyperbolic curve) stores O2 and facilitates diffusion from blood to mitochondria.

Clinical and physiological considerations

• Haemoglobin concentration: Anaemia lowers total O2 content even if SaO2 is normal.
• Carbon monoxide (CO) poisoning: CO binds Hb with much higher affinity forming carboxyhaemoglobin, reducing O2 carrying capacity and shifting curve to left for remaining binding sites.
• Altitude: Lower ambient PO2 reduces arterial PO2 and O2 saturation; acclimatization includes ↑ 2,3-BPG and ↑ RBC production.

Typical numerical values (for students)

• Normal Hb ≈ 15 g/dL (male), O2 binding capacity ≈ 1.34 mL O2 per g Hb.
• Arterial PO2 ≈ 95–100 mmHg → SaO2 ≈ 95–100%.
• Venous PO2 ≈ 40 mmHg → SvO2 ≈ 70–75%.

Fig 12 — Educational Diagram: Oxygen-Hemoglobin Dissociation Curve

What it is: The oxygen–hemoglobin dissociation curve (O2–Hb curve) is a plot of percent hemoglobin saturation (SaO2, y-axis) versus partial pressure of oxygen in blood (PO2, x-axis, usually mmHg). It shows how readily hemoglobin picks up O2 in the lungs and releases it in tissues.

Shape and cause: The curve is sigmoid (S-shaped) because of cooperative binding: when one O2 binds to a hemoglobin (Hb) subunit, the protein changes conformation to increase the affinity of the remaining subunits for O2. This gives a steep middle portion (efficient O2 loading/unloading over physiological PO2 range) and a plateau at high PO2 (safety margin in the lungs).

Key points on the curve:

• P50: PO2 at which Hb is 50% saturated (normal P50 ≈ 26–27 mmHg). It is an index of hemoglobin’s affinity for O2 (lower P50 = higher affinity).
• Plateau region (PO2 > ~60 mmHg): SaO2 remains high despite moderate drops in PO2 — important for arterial oxygenation safety.
• Steep region (PO2 ~20–60 mmHg): small changes in PO2 produce large changes in O2 unloading — ideal for tissue oxygen delivery.

Factors shifting the curve:

• Right shift (↓ affinity, easier O2 unloading): increased CO2, decreased pH (Bohr effect), increased temperature, increased 2,3-bisphosphoglycerate (2,3-BPG). Clinical/physiologic examples: active muscles during exercise (heat, ↑CO2, ↓pH) or chronic hypoxia (↑2,3-BPG).
• Left shift (↑ affinity, harder O2 unloading): decreased CO2, increased pH, decreased temperature, fetal hemoglobin (HbF), carbon monoxide (CO) binding to Hb (reduces available sites and increases affinity at remaining sites). Example: fetal blood picks up O2 from maternal blood because HbF is left-shifted.

Physiological significance: The S-shape plus shifts allow hemoglobin to load O2 efficiently in the lungs (high PO2) and release it in metabolically active tissues (lower PO2). Modulation by pH, CO2, temperature and 2,3-BPG matches O2 delivery to tissue demand.

Clinical relevance: Pulse oximetry measures SaO2 (but not total O2 content). Conditions like anemia, CO poisoning, or abnormal hemoglobins change O2 content or the curve and thereby affect tissue oxygenation. P50 is used diagnostically to assess changes in Hb affinity.

Fig 13 — Educational Diagram: Transport of Carbon Dioxide in Blood

Overview
Carbon dioxide (CO2) produced by cellular respiration is transported from tissues to the lungs in blood by three main means: dissolved in plasma, chemically as bicarbonate (HCO3–), and bound to proteins (mainly haemoglobin as carbamino compounds). These processes keep blood pH relatively stable and facilitate efficient gas exchange in the lungs.

Proportions of CO2 transport

• ~5–7% dissolved directly in plasma
• ~70% as bicarbonate ions (HCO3–) formed inside red blood cells
• ~20–25% as carbamino compounds (mainly carbaminohaemoglobin)

Detailed mechanism

• At the tissues (CO2 loading):
  • CO2 produced by cells diffuses into plasma and into red blood cells (RBCs).
  • Inside RBCs, carbonic anhydrase catalyzes: CO2 + H2O ⇌ H2CO3 (carbonic acid).
  • H2CO3 rapidly dissociates: H2CO3 ⇌ H+ + HCO3–. Bicarbonate (HCO3–) diffuses out of RBCs into plasma in exchange for Cl– (the chloride shift or Hamburger phenomenon), maintaining electroneutrality.
  • H+ produced binds to haemoglobin (Hb) and other buffers, minimizing pH change. Deoxygenated Hb binds H+ better, aiding buffering and supporting CO2 uptake (Haldane effect).
  • Some CO2 reacts directly with terminal amino groups on haemoglobin to form carbaminohaemoglobin: Hb-NH2 + CO2 ⇌ Hb-NH-COO– + H+.
• At the lungs (CO2 unloading):
  • PCO2 in alveoli is low compared with venous blood, so CO2 diffuses from blood into alveolar air.
  • As CO2 leaves RBCs, bicarbonate re-enters RBCs (chloride shift reverses) and combines with H+ to form H2CO3, which carbonic anhydrase converts to CO2 and H2O: H+ + HCO3– ⇌ H2CO3 ⇌ CO2 + H2O.
  • Oxygenation of haemoglobin in the lungs reduces Hb’s affinity for H+ and CO2 (Bohr and Haldane effects), promoting CO2 release.

Important physiological effects

• Chloride shift maintains ionic balance and facilitates bicarbonate transport in plasma.
• Haldane effect: deoxygenated haemoglobin binds CO2 and H+ more readily — this helps transport CO2 from tissues to lungs.
• Bohr effect: increased CO2 and H+ lower Hb affinity for O2, promoting O2 release in tissues.

Summary (flow)
Tissues: CO2 → RBC → (carbonic anhydrase) → HCO3– (out) + H+ (binds Hb) + some CO2 binds Hb → Blood carries CO2 to lungs → In lungs reverse reactions → CO2 released to alveoli.

Fig 14 — Educational Diagram: Chloride Shift and Blood Buffering

Overview
Chloride shift (Hamburger phenomenon) and blood buffering are closely linked processes that allow blood to transport CO2 from tissues to lungs while keeping pH and electrical neutrality of red blood cells (RBCs) stable.

Chloride shift — mechanism (tissues → blood)

• CO2 produced by metabolizing tissues diffuses into plasma and into RBCs.
• Inside RBCs, carbonic anhydrase catalyzes: CO2 + H2O ⇌ H2CO3 (carbonic acid), which rapidly dissociates to H+ + HCO3−.
• HCO3− concentration rises inside RBCs. To maintain electrical neutrality and osmotic balance, HCO3− is transported out of the RBC into plasma in exchange for Cl− moving into the RBC via the band 3 anion exchanger (AE1). This is the chloride shift.
• Meanwhile H+ produced is largely buffered by haemoglobin (Hb). Deoxygenated Hb (HHb) has high affinity for H+ and so acts as an intracellular buffer, preventing large drops in pH.

Reverse process in the lungs (blood → alveoli)

• In pulmonary capillaries PO2 is high and O2 binds Hb, promoting release of H+ from Hb. H+ combines with HCO3− re-entering RBCs (HCO3− moves into RBCs in exchange for Cl− moving out) to form H2CO3, which carbonic anhydrase converts to CO2 + H2O.
• CO2 diffuses into alveoli and is exhaled. Net effect: HCO3− and Cl− movements reverse and CO2 is eliminated.

Why chloride shift matters

• Prevents accumulation of HCO3− inside RBCs allowing continued conversion of CO2 to HCO3−.
• Maintains electrical neutrality of RBCs (Cl− compensates for leaving HCO3−).
• Supports efficient CO2 transport (~70% transported as HCO3− in plasma).

Blood buffering systems

• Bicarbonate buffer (major extracellular buffer): CO2/H2CO3/HCO3− system buffers changes in pH. Carbonic anhydrase speeds conversion between CO2 and H2CO3 inside RBCs and pulmonary endothelium.
  • Physiological Henderson–Hasselbalch form: pH = 6.1 + log([HCO3−] / (0.03 × PaCO2)), where 0.03 is the solubility coefficient (mmol·L−1·mmHg−1) and PaCO2 in mmHg.
• Haemoglobin as an intracellular buffer:
  • Deoxyhaemoglobin binds H+ (and CO2 as carbamino compounds) better than oxyhaemoglobin. This reduces free H+ concentration in RBCs and stabilizes pH.
  • Binding of H+ to Hb facilitates O2 unloading in tissues (Bohr effect): increased CO2/H+ shifts oxyhaemoglobin dissociation curve to the right, enhancing O2 release.
• Other buffers: plasma proteins (albumin), phosphate buffer (important in intracellular and renal buffering).

Integration — link between chloride shift and buffering
The outward movement of HCO3− (chloride shift) prevents intracellular accumulation of negative charge and allows continuous conversion of CO2 → HCO3−. H+ left inside the RBC are buffered primarily by Hb. Without chloride shift, HCO3− would accumulate in RBCs and hamper CO2 transport and intracellular pH balance.

Clinical relevance / physiological examples
During exercise tissues produce more CO2 → more HCO3− formation and larger chloride shift; blood gas measurements (PaCO2, HCO3−, Cl−) help diagnose respiratory and metabolic acidosis/alkalosis. Hyperventilation lowers PaCO2 causing respiratory alkalosis; hypoventilation raises PaCO2 causing respiratory acidosis. Kidneys compensate by adjusting HCO3− reabsorption/secretion.

Fig 15 — Educational Diagram: Internal Respiration (Tissue Gas Exchange)

What is internal respiration? Internal respiration (tissue gas exchange) is the set of processes by which oxygen (O2) leaves the systemic blood and diffuses into body cells, and carbon dioxide (CO2) produced by cells diffuses into systemic blood. This exchange occurs across the walls of systemic capillaries and the interstitial fluid, driven primarily by differences in partial pressures (partial pressure gradients).

Mechanism — step by step

• Partial pressure gradients: Tissue PO2 is lower (≈ 40 mm Hg at rest) than arterial/capillary PO2 (≈ 100 mm Hg), so O2 diffuses from blood → tissues. Tissue PCO2 is higher (≈ 45 mm Hg) than blood/capillary PCO2 (≈ 40 mm Hg), so CO2 diffuses from tissues → blood.
• Oxygen transport and unloading: Most O2 in arterial blood is bound to haemoglobin (Hb) in RBCs. When PO2 falls in tissues, Hb releases O2 (dissociation). The amount unloaded depends on the oxygen-haemoglobin dissociation curve and factors that shift it (Bohr effect, temperature, 2,3-BPG, etc.). Myoglobin in muscle stores/facilitates intracellular O2 diffusion.
• Carbon dioxide transport: CO2 enters blood by diffusion and is transported as (1) dissolved CO2, (2) bicarbonate ion (HCO3-, the major form), and (3) carbamino compounds (CO2 bound to amino groups of haemoglobin and plasma proteins).
• Carbonic anhydrase and chloride shift: In RBCs the enzyme carbonic anhydrase catalyses CO2 + H2O ⇌ H2CO3 ⇌ H+ + HCO3-. Generated HCO3- exits RBCs into plasma in exchange for Cl- (chloride shift or Hamburger phenomenon), maintaining electroneutrality.
• Buffering: H+ produced by CO2 hydration is buffered by haemoglobin and other buffers; deoxygenated haemoglobin is a better H+ acceptor, facilitating CO2 transport.

Factors that increase O2 unloading at tissues (shift dissociation curve to the right)

• Lower PO2 in tissues (greater gradient)
• Higher PCO2
• Lower pH (acidosis) — Bohr effect
• Higher temperature
• Increased 2,3-bisphosphoglycerate (2,3-BPG) in RBCs

Physiological numbers and meaning

• Typical arterial PO2 ≈ 95–100 mm Hg; arterial O2 saturation ≈ 97%.
• Typical mixed venous PO2 ≈ 40 mm Hg; venous O2 saturation ≈ 75%.
• Oxygen extraction fraction at rest ≈ 25% (about 5 ml O2 per 100 ml blood is removed by tissues; arterial O2 content ≈ 20 ml O2/100 ml blood, venous ≈ 15 ml/100 ml).

Clinical/physiological notes

• During exercise, tissue PO2 falls and PCO2 rises; curve shifts to the right and more O2 is unloaded per unit blood (extraction can rise to 50% or more).
• In cyanide poisoning, tissues cannot use O2 (cellular respiration blocked), so venous PO2 remains high despite normal oxygen delivery.

Fig 16 — Educational Diagram: Regulation of Respiration

Overview
Regulation of respiration is the set of neural and chemical mechanisms that maintain adequate pulmonary ventilation to meet the body’s metabolic needs and to keep arterial PO2, PCO2 and pH within narrow limits. The system constantly adjusts breathing rate and depth (tidal volume) in response to changes in CO2, O2, pH, lung stretch and behavioural demands (speech, exercise, emotion).

Central neural centres
The main respiratory centres lie in the brainstem (medulla and pons):

• Medulla oblongata: contains the dorsal respiratory group (DRG) — primarily inspiratory neurons that set the basic rhythm — and the ventral respiratory group (VRG) — contains both inspiratory and expiratory neurons used for forced breathing.
• Pons: contains the pneumotaxic (limits inspiration, promotes rhythmicity and increases breathing rate by shortening inspiration) and apneustic centres (promote prolonged inspiration); they modulate medullary output for smooth transitions between inspiration and expiration.

Chemoreceptors — chemical control
Chemoreceptors monitor gases and pH and produce reflex changes in ventilation:

• Central chemoreceptors (on the ventrolateral surface of the medulla) primarily respond to changes in [H+] in the cerebrospinal fluid produced by CO2 diffusing into the CSF. Because H+ cannot cross the blood–brain barrier, CO2 diffuses and reacts with H2O to form H+ (via carbonic anhydrase), so arterial PCO2 is the major stimulus for central chemoreceptors.
• Peripheral chemoreceptors (carotid bodies at the bifurcation of the common carotid and aortic bodies on the aortic arch) respond to decreases in arterial PO2 (strong stimulus when PO2 < ~60 mm Hg), increases in PCO2 and fall in pH. Carotid bodies are especially important in acute hypoxia.

Other receptors and inputs
Pulmonary stretch receptors (slowly adapting stretch receptors) mediate the Hering–Breuer inflation reflex to inhibit inspiration when lungs are overly inflated. Rapidly adapting irritant receptors and juxtacapillary (J) receptors respond to smoke, mucus, pulmonary congestion and cause cough or rapid, shallow breathing. Proprioceptors in muscles and joints, and input from higher centres (cerebral cortex, limbic system) alter ventilation during exercise, speech, emotion, voluntary breath-holding and anticipatory changes.

Feedback and integration
The medullary respiratory network integrates chemical signals (from chemoreceptors), mechanical signals (from lung and airway receptors) and higher brain inputs to adjust the motor output to respiratory muscles. The dominant long-term regulator of ventilation is arterial PCO2 via central chemoreceptors; arterial PO2 becomes a strong driver only when it falls substantially. The result is tight regulation of PaCO2 (around 40 mm Hg) and arterial pH.

Examples of physiological responses
- Hypercapnia (rise in arterial PCO2) → increased H+ in CSF → increased firing of central chemoreceptors → increased ventilation (rate & depth).
- Hypoxia (low arterial PO2) → stimulation of peripheral chemoreceptors → increased ventilation (especially when PO2 < 60 mm Hg).
- Exercise: immediate increase in ventilation from neural (“central command” and proprioceptor) input; later matched and fine-tuned by chemoreceptor feedback to remove CO2 produced by muscles.
- High altitude: reduced PO2 stimulates peripheral chemoreceptors → sustained hyperventilation (acute), with further adaptations (increased RBCs) during acclimatization.

Pathophysiological notes
In chronic lung disease (e.g., advanced COPD) chronically elevated PaCO2 can reduce central chemoreceptor sensitivity; ventilation may be driven more by hypoxia (the so-called hypoxic drive). Disorders like sleep apnea involve impaired neural control leading to episodic cessation of breathing.

Key chemical reaction (mechanistic basis)
CO2 + H2O ⇌ H2CO3 ⇌ H+ + HCO3- (carbonic anhydrase accelerates reaction). Changes in arterial PCO2 rapidly alter CSF H+ (and thus central chemoreceptor activity) and arterial pH affects peripheral chemoreceptors.

Summary
Respiration is regulated by an interaction of medullary and pontine neuronal centres, peripheral and central chemoreceptors, lung and airway receptors, and higher brain inputs. CO2 (via central chemoreceptors) is the most powerful regulator of ventilation; O2 (via peripheral chemoreceptors) is critical when arterial PO2 falls markedly.

Fig 17 — Educational Diagram: Chemical Control and Chemoreceptors

Overview
Chemical control of respiration is the regulation of ventilation (rate and depth of breathing) by sensing changes in blood/CSF gases and pH. Chemoreceptors detect levels of O2, CO2 and H+ and adjust the activity of respiratory centres in the brainstem (medulla and pons) to maintain homeostasis.

Types and Locations of Chemoreceptors

• Central chemoreceptors — located on the ventrolateral surface of the medulla oblongata. They are highly sensitive to changes in pH of the cerebrospinal fluid (CSF) that reflect arterial CO2 (PaCO2).
• Peripheral chemoreceptors — located in the carotid bodies at the bifurcation of the common carotid arteries and in the aortic bodies above and below the aortic arch. They respond mainly to low arterial O2 partial pressure (PaO2), and secondarily to increased PaCO2 and decreased pH.

How they work (mechanism)

1. CO2 produced by tissues diffuses into blood and across the blood–brain barrier into CSF because CO2 is highly permeable. In CSF, CO2 reacts with H2O to produce H+ and HCO3− (reaction catalysed in blood by carbonic anhydrase; CSF has limited buffering).
2. Because the blood–brain barrier is relatively impermeable to H+, changes in PaCO2 alter CSF pH. Central chemoreceptors detect the resulting change in [H+] (i.e., pH) and stimulate the respiratory centre to change ventilation.
3. Peripheral chemoreceptors in carotid and aortic bodies directly sense falls in PaO2 (especially when PaO2 < ~60 mmHg), increases in PaCO2 and acidosis. They send afferent signals — via the glossopharyngeal nerve (CN IX) from carotid bodies and the vagus nerve (CN X) from aortic bodies — to the respiratory centres, which increase ventilation.

Relative sensitivities
Central chemoreceptors are the primary sensors for PaCO2 (and resultant pH) and account for most of the ventilatory response to small changes in PaCO2. Peripheral chemoreceptors are the main sensors for hypoxia (low PaO2) and contribute to responses to CO2 and pH; they are especially important when PaO2 falls below ~60 mmHg.

Physiological response
An increase in PaCO2 (hypercapnia) raises [H+] in CSF → central chemoreceptor stimulation → increased rate and depth of breathing (hyperventilation) to lower PaCO2. A fall in PaO2 triggers peripheral chemoreceptors → increased ventilation. Metabolic acidosis (primary fall in blood H+) stimulates peripheral chemoreceptors and causes hyperventilation (compensatory respiratory alkalosis).

Clinical relevance / examples
- High altitude: lower PaO2 → strong peripheral chemoreceptor activation → hyperventilation.
- Exercise: increased CO2 production and H+ (from metabolism) increases ventilation via chemoreceptor stimulation plus neural inputs.
- COPD: chronic hypercapnia leads to central chemoreceptor desensitisation; ventilation may be driven more by hypoxic (peripheral) drive — clinical caution with supplemental O2.
- Diabetic ketoacidosis: metabolic acidosis → peripheral chemoreceptor stimulation → Kussmaul breathing (deep, fast breaths) as compensation.

Integration with neural control
Chemical control works together with neural inputs (corticospinal, proprioceptive, pulmonary stretch receptors) to fine-tune ventilation. Chemoreceptor signals target inspiratory and expiratory neurons in medullary respiratory centres and pontine centres to alter rhythm and depth.

Normal reference values (approx.)
Arterial pH: 7.35–7.45; PaCO2: ~40 mmHg; PaO2: ~95 mmHg. Peripheral chemoreceptor hypoxic response becomes strong when PaO2 < ~60 mmHg.

Summary
Chemoreceptors are essential for rapid, automatic regulation of breathing in response to changes in blood gases and pH. Central chemoreceptors primarily sense CO2 via CSF pH changes; peripheral chemoreceptors primarily sense arterial O2 and also respond to CO2 and H+.

Fig 18 — Educational Diagram: Adaptations for Increased Oxygen Demand

Overview
When tissues require more O2 (exercise, cold, altitude, diving), organisms use short-term physiological responses and long-term structural/biochemical adaptations to increase O2 uptake, transport and use. These adaptations act on ventilation, circulatory delivery, O2-carrying capacity, and cellular O2 use.

Short‑term (seconds–minutes)

• Increased ventilation (hyperpnea): respiratory rate (RR) and tidal volume (TV) rise to increase minute ventilation and alveolar ventilation so more O2 reaches blood. Peripheral chemoreceptors (carotid bodies) detect low PO2 and central chemoreceptors respond to CO2/pH changes to drive this.
• Increased cardiac output (CO): heart rate (HR) and stroke volume (SV) increase so more O2‑rich blood is delivered per minute. Blood flow is redistributed to active muscles by vasodilation there and vasoconstriction in nonessential beds.
• Faster O2 unloading in tissues: local increases in CO2, H+, temperature and 2,3‑BPG produce a right shift of the Hb–O2 dissociation curve (Bohr effect), enhancing O2 release.

Long‑term (days–weeks or training/acclimatization)

• Increased O2‑carrying capacity: higher RBC production (erythropoiesis) and Hb concentration (polycythemia) at altitude; increased 2,3‑BPG shifts curve to favor tissue unloading.
• Muscle adaptations: increased capillary density, mitochondrial number, and myoglobin concentration improve O2 extraction and intracellular storage.
• Structural respiratory adaptations (species‑specific): birds — highly efficient unidirectional flow and parabronchi for continuous gas exchange; diving mammals — large blood and muscle O2 stores (high Hb and myoglobin), bradycardia and peripheral vasoconstriction during dives; insects — extensive tracheal systems and air‑sacs, sometimes active ventilation.

How these changes work together
Ventilation increases alveolar PO2, CO increases delivery; Hb and myoglobin store and buffer O2; capillary and mitochondrial density increase extraction; Bohr effect and temperature changes speed unloading where needed. These combined changes raise VO2 (oxygen uptake) and delay anaerobic metabolism.

Clinical/physiological notes
Immediate increases in VE and CO meet mild–moderate demands. At very high intensities, oxygen delivery becomes limiting and anaerobic metabolism rises (lactate accumulation). Chronic altitude exposure increases erythropoietin (EPO), RBC mass and 2,3‑BPG. Excessive polycythemia increases blood viscosity, which can impair flow.

Fig 19 — Educational Diagram: Respiratory Disorders and Defensive Mechanisms

Overview: The respiratory system has multiple physical, cellular and humoral defenses to keep inhaled pathogens, particles and irritants from damaging airways and gas-exchanging surfaces. When these defenses fail or are overwhelmed, a range of respiratory disorders can occur — from mild upper respiratory infections to chronic obstructive disease and life‑threatening pneumonia.

Defensive mechanisms (how the system protects itself)

• Physical/anatomical barriers: Nasal hairs, turbinates, and mucus trap large particles; branching of airways filters particles by impaction.
• Mucociliary escalator: Goblet cells and submucosal glands produce mucus; ciliated epithelial cells beat to move mucus and trapped microbes upward to be swallowed or expelled (coughing).
• Reflexes: Cough and sneeze expel irritants; bronchoconstriction limits entry of harmful substances.
• Cellular defenses: Alveolar macrophages phagocytose inhaled microbes and particulates; recruited neutrophils combat infections.
• Humoral defenses: Secretory IgA in mucosal secretions, lysozyme, defensins and complement in airways help neutralize microbes.
• Surfactant: Lowers surface tension, maintains alveolar stability and helps opsonize pathogens for macrophages.

When defenses fail: Impaired mucociliary clearance (smoking, viral infection), thickened mucus (cystic fibrosis), decreased macrophage function (alcohol, some diseases), or structural damage (emphysema) predispose to infections and chronic inflammation.

Common respiratory disorders — mechanisms, features & relation to defenses

• Common cold / viral rhinitis: Viral infection of nasal mucosa → inflammation, increased mucus, sneezing. Mucosal IgA and interferons are important defenses.
• Sinusitis / pharyngitis / laryngitis: Extension of mucosal infections; obstruction of drainage can allow bacterial overgrowth.
• Bronchitis (acute & chronic): Acute typically viral/bacterial inflammation of bronchi. Chronic bronchitis (a COPD component) results from long-term irritant exposure (smoking) → mucus gland hyperplasia, increased secretions and productive cough. Impaired mucociliary clearance leads to recurrent infections.
• Asthma: Hyperresponsiveness of airways to allergens or irritants → bronchoconstriction, inflammation and mucous secretion. IgE-mediated mast cell degranulation (allergic asthma) releases histamine and leukotrienes; reversible airflow obstruction is typical.
• Emphysema: Destruction of alveolar walls (loss of elastic recoil) → enlarged air spaces, reduced surface area for gas exchange; smoking causes inflammation and protease/antiprotease imbalance. Leads to breathlessness and impaired gas exchange.
• Chronic obstructive pulmonary disease (COPD): Combination of chronic bronchitis and emphysema leading to persistent airflow limitation, hypoxia and hypercapnia in advanced stages.
• Pneumonia: Infection of alveoli (bacterial, viral, fungal) → alveolar consolidation, impaired diffusion and hypoxia. Defense failure (aspiration, immunosuppression) predisposes to pneumonia.
• Tuberculosis (TB): Mycobacterium tuberculosis infection triggers granuloma formation (caseating granulomas) in lungs; cell-mediated immunity walls off bacilli but can cause tissue damage.
• Pneumothorax & pleural effusion: Air or fluid in pleural space compresses lung and reduces ventilation (mechanical, not infectious).
• Cystic fibrosis: Genetic CFTR defect → thick, sticky mucus; poor mucociliary clearance → chronic bacterial infections and bronchiectasis.
• Occupational pneumoconioses (silicosis, asbestosis, coal worker’s): Inhaled particles produce chronic inflammation and fibrosis; macrophage overload and death contribute to disease.

Clinical consequences of defense failure: Recurrent infections, chronic inflammation, airway remodeling (permanent structural change), reduced diffusion capacity and impaired ventilation–perfusion matching, all of which reduce oxygenation and exercise tolerance.

Prevention & supportive measures: Smoking cessation (restores ciliary function over time), vaccinations (influenza, pneumococcal), good hygiene to reduce spread of microbes, avoiding occupational exposures, bronchodilators and anti-inflammatory drugs to control asthma/COPD, chest physiotherapy and antibiotics when indicated.

Fig 20 — Educational Diagram: Effects of Smoking and Pollution on Respiratory System

Overview
Smoking (active and passive) and air pollution (ambient particulate matter, NOx, SO2, ozone, biomass smoke) damage the respiratory system by mechanical injury, chemical irritation, inflammation and by impairing gas exchange. The result is acute symptoms (cough, breathlessness, increased infections) and chronic diseases (chronic bronchitis, emphysema, COPD, lung cancer, pulmonary hypertension).

How tobacco smoke and pollutants reach and injure the respiratory tract

• Large particles deposit in the nasal cavity and upper airways; smaller particles (PM2.5, ultrafine particles) and gases reach bronchioles and alveoli.
• Toxic components of cigarette smoke: nicotine (addictive), tar (carcinogens), carbon monoxide (CO, binds haemoglobin), reactive oxygen species and irritant gases. Pollutants (PM2.5, ozone, NO2, SO2) produce oxidative stress and inflammation.

Key pathophysiological mechanisms

• Ciliary dysfunction and mucus hypersecretion: Smoke/par ticles damage ciliated epithelium and increase goblet cells → impaired mucociliary escalator → mucus retention, chronic cough, recurrent infections.
• Chronic inflammation: Persistent neutrophilic and macrophage-mediated inflammation releases proteases and reactive oxygen species → tissue damage.
• Protease–antiprotease imbalance and alveolar destruction: Proteases (eg, elastase) destroy alveolar walls → emphysema → ↓alveolar surface area for gas exchange and ↑dead space.
• Airway remodeling and obstruction: Smooth muscle hypertrophy, fibrosis and mucus plugging → increased airway resistance → obstructive pattern (reduced FEV1/FVC).
• Diffusion impairment and V/Q mismatch: Alveolar wall destruction and inflammation increase diffusion distance and cause areas with poor ventilation or perfusion → hypoxaemia.
• Carbon monoxide effects: CO binds hemoglobin with high affinity forming carboxyhaemoglobin (COHb) → decreases O2-carrying capacity and shifts oxyhemoglobin dissociation curve left → reduced O2 delivery to tissues.
• Carcinogenesis: DNA damage by carcinogens → mutations in oncogenes/tumour suppressors → lung cancer (bronchogenic carcinoma).

Clinical consequences

• Acute: increased airway reactivity (wheezing), exacerbation of asthma, upper respiratory infections.
• Chronic: chronic bronchitis (productive cough for >2 yrs), emphysema (dyspnoea, barrel chest), chronic obstructive pulmonary disease (COPD), pulmonary hypertension, right heart failure (cor pulmonale), lung cancer, reduced exercise tolerance.

Functional changes measurable by tests

• Spirometry: reduced FEV1, reduced FEV1/FVC (obstructive pattern); progressive decline in FEV1 with continued smoking.
• Diffusing capacity (DLCO): reduced in emphysema due to loss of alveolar-capillary surface area.
• Arterial blood gases: hypoxaemia (↓PaO2) and possible hypercapnia in advanced disease; elevated COHb in smokers.

Prevention and public-health relevance
Avoid exposure (smoking cessation, smoke-free laws), reduce ambient pollution (emission controls, masks in high-smog episodes), vaccination against respiratory pathogens, early diagnosis and pulmonary rehabilitation reduce morbidity and mortality.